Anemia in pregnancy: Clinical sciences

2,179views

Anemia in pregnancy: Clinical sciences

Watch later

Watch later

Attention deficit hyperactivity disorder (ADHD): Clinical sciences
Premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD): Clinical sciences
Alcohol use disorder: Clinical sciences
Alcohol withdrawal: Clinical sciences
Selective serotonin reuptake inhibitors
Atypical antidepressants
Monoamine oxidase inhibitors
Serotonin and norepinephrine reuptake inhibitors
Tricyclic antidepressants
Atypical antipsychotics
Typical antipsychotics
Anticonvulsants and anxiolytics: Benzodiazepines
Nonbenzodiazepine anticonvulsants
Psychomotor stimulants
Malaria: Clinical sciences
Sickle cell disease: Clinical sciences
Multiple myeloma: Clinical sciences
Zika virus
Dengue virus
Human T-lymphotropic virus
Trichuris trichiura (Whipworm)
Ancylostoma duodenale and Necator americanus
Babesia
Plasmodium species (Malaria)
Diphyllobothrium latum
Anticoagulants: Warfarin
Anticoagulants: Direct factor inhibitors
Anticoagulants: Heparin
Antimalarials
Antiplatelet medications
Thrombolytics
Hematopoietic medications
Dyslipidemia: Clinical sciences
Congestive heart failure: Clinical sciences
Infectious endocarditis: Clinical sciences
Cardiovascular disease screening: Clinical sciences
Deep vein thrombosis: Clinical sciences
Vasculitis: Pathology review
Adrenergic antagonists: Beta blockers
Calcium channel blockers
cGMP mediated smooth muscle vasodilators
Class I antiarrhythmics: Sodium channel blockers
Class II antiarrhythmics: Beta blockers
Class III antiarrhythmics: Potassium channel blockers
Class IV antiarrhythmics: Calcium channel blockers and others
ACE inhibitors, ARBs and direct renin inhibitors
Thiazide and thiazide-like diuretics
Lipid-lowering medications: Fibrates
Lipid-lowering medications: Statins
Miscellaneous lipid-lowering medications
Pheochromocytoma: Clinical sciences
Adrenal insufficiency: Clinical sciences
Primary aldosteronism (hyperaldosteronism): Clinical sciences
Multiple endocrine neoplasia: Clinical sciences
Hyperparathyroidism: Clinical sciences
Syndrome of inappropriate antidiuretic hormone secretion: Clinical sciences
Neuroendocrine tumors of the gastrointestinal system: Pathology review
Hypopituitarism: Pathology review
Pituitary tumors: Pathology review
Hyperthyroidism: Pathology review
Hypothyroidism medications
Alcohol-induced hepatitis: Clinical sciences
Cirrhosis: Clinical sciences
Gastroesophageal reflux disease: Clinical sciences
Acute pancreatitis: Clinical sciences
Pilonidal disease: Clinical sciences
Hemorrhoids: Clinical sciences
Perianal abscess and fistula: Clinical sciences
Anal fissure: Clinical sciences
Appendicitis: Clinical sciences
Diverticulitis: Clinical sciences
Irritable bowel syndrome: Clinical sciences
Gastritis: Clinical sciences
Peptic ulcer disease: Clinical sciences
Stress ulcers: Clinical sciences
Celiac disease: Clinical sciences
Inflammatory bowel disease (ulcerative colitis): Clinical sciences
Inflammatory bowel disease (Crohn disease): Clinical sciences
Infectious gastroenteritis: Clinical sciences
Esophageal cancer: Clinical sciences
Anal cancer: Clinical sciences
Colorectal cancer: Clinical sciences
Gastric cancer: Clinical sciences
Femoral hernias: Clinical sciences
Umbilical hernias: Clinical sciences
Inguinal hernias: Clinical sciences
Helicobacter pylori
Vibrio cholerae (Cholera)
Colorectal polyps and cancer: Pathology review
Acid reducing medications
Antidiarrheals
Hepatitis medications
Laxatives and cathartics
Well-patient care (adult): Clinical sciences
Well-patient care (GYN): Clinical sciences
Breast cancer screening: Clinical sciences
Carotid artery stenosis screening: Clinical sciences
Cervical cancer screening: Clinical sciences
Colorectal cancer screening: Clinical sciences
Sexually transmitted infection screening (GYN): Clinical sciences
Skin cancer screening: Clinical sciences
Anaphylaxis: Clinical sciences
Glucocorticoids
Non-corticosteroid immunosuppressants and immunotherapies
Hemochromatosis: Clinical sciences
Henoch-Schonlein purpura: Clinical sciences
Systemic lupus erythematosus: Clinical sciences
Reactive arthritis: Clinical sciences
Temporal arteritis: Clinical sciences
Systemic sclerosis (scleroderma): Clinical sciences
Infectious mononucleosis: Clinical sciences
Lyme disease: Clinical sciences
Burns: Clinical sciences
Hypothermia: Clinical sciences
Yellow fever virus
Seronegative and septic arthritis: Pathology review
Water-soluble vitamin deficiency and toxicity: B1-B7: Pathology review
Fat-soluble vitamin deficiency and toxicity: Pathology review
Water-soluble vitamin deficiency and toxicity: B9, B12 and vitamin C: Pathology review
Zinc deficiency and protein-energy malnutrition: Pathology review
Environmental and chemical toxicities: Pathology review
Antimetabolites: Sulfonamides and trimethoprim
Cell wall synthesis inhibitors: Cephalosporins
Cell wall synthesis inhibitors: Penicillins
DNA synthesis inhibitors: Metronidazole
DNA synthesis inhibitors: Fluoroquinolones
Miscellaneous cell wall synthesis inhibitors
Miscellaneous protein synthesis inhibitors
Protein synthesis inhibitors: Aminoglycosides
Protein synthesis inhibitors: Tetracyclines
Azoles
Anthelmintic medications
Herpesvirus medications
Osteoporosis: Clinical sciences
Mechanical back pain: Clinical sciences
Gout: Clinical sciences
Calcium pyrophosphate deposition disease (pseudogout): Clinical sciences
Osteoarthritis: Clinical sciences
Inflammatory myopathies: Clinical sciences
Osteomyelitis: Clinical sciences
Septic arthritis: Clinical sciences
Compartment syndrome: Clinical sciences
Anatomy clinical correlates: Bones, joints and muscles of the back
Anatomy clinical correlates: Knee
Anatomy clinical correlates: Leg and ankle
Antigout medications
Osteoporosis medications
Subarachnoid hemorrhage: Clinical sciences
Otitis media and externa (pediatrics): Clinical sciences
Multiple sclerosis: Clinical sciences
Myasthenia gravis: Clinical sciences
West Nile virus
Adult brain tumors: Pathology review
Local anesthetics
Migraine medications
Adrenergic antagonists: Alpha blockers
Medications for neurodegenerative diseases
Preconception care: Clinical sciences
Antepartum care (first trimester): Clinical sciences
Antepartum care (second trimester): Clinical sciences
Antepartum care (third trimester): Clinical sciences
Cytomegalovirus (CMV), parvovirus B19, varicella zoster, and toxoplasmosis infection in pregnancy: Clinical sciences
Group B streptococcus (GBS) colonization in pregnancy: Clinical sciences
Herpes simplex virus infection in pregnancy: Clinical sciences
Anemia in pregnancy: Clinical sciences
Early pregnancy loss: Clinical sciences
Ectopic pregnancy: Clinical sciences
Nausea and vomiting of pregnancy: Clinical sciences
Therapeutic and induced abortions: Clinical sciences
Asthma in pregnancy: Clinical sciences
Urinary tract infections and kidney stones in pregnancy: Clinical sciences
Venous thromboembolism in pregnancy: Clinical sciences
Estrogens and antiestrogens
Progestins and antiprogestins
Lower urinary tract infection: Clinical sciences
Pyelonephritis: Clinical sciences
Approach to acute kidney injury: Clinical sciences
Chronic kidney disease: Clinical sciences
Nephrolithiasis: Clinical sciences
BK virus (Hemorrhagic cystitis)
Fibroadenoma: Clinical sciences
Fibrocystic breast changes: Clinical sciences
Breast papilloma: Clinical sciences
Infertility: Clinical sciences
Uterine leiomyoma: Clinical sciences
Perimenopause, menopause, and primary ovarian insufficiency: Clinical sciences
Benign prostatic hypertrophy and prostate cancer: Clinical sciences
Testicular cancer: Clinical sciences
Benign breast conditions: Pathology review
Penile conditions: Pathology review
PDE5 inhibitors
Asthma: Clinical sciences
Sleep apnea: Clinical sciences
Coxiella burnetii (Q fever)
Legionella pneumophila (Legionnaires disease and Pontiac fever)
Pleural effusion, pneumothorax, hemothorax and atelectasis: Pathology review
Antihistamines for allergies
Bronchodilators: Beta 2-agonists and muscarinic antagonists
Bronchodilators: Leukotriene antagonists and methylxanthines
Pulmonary corticosteroids and mast cell inhibitors
Benign skin lesions: Clinical sciences
Chest X-ray interpretation: Clinical sciences

Decision-Making Tree

Questions

USMLE® Step 2 style questions USMLE

0 of 3 complete

Start
A 29-year-old G1P0 woman at 15 weeks gestation presents to the primary care clinic for evaluation of fatigue for the past three weeks. She has had minimal pregnancy-associated weight gain secondary to daily nausea and vomiting multiple times a day. The nausea and vomiting have improved since she entered the second trimester, and she currently has nausea with vomiting several times each week. Current medications include prenatal vitamins. Vital signs are within normal limits. On physical examination, the patient is comfortable and in no acute distress. There is no tenderness to palpation of the abdomen, and she has a gravid uterus appropriate for gestational age. Laboratory studies are shown below. Which of the following is the most appropriate treatment for this patient?

 Laboratory Test     Serum Value     Reference Range    
 Hemoglobin     10 g/dL     12-16 g/dL    
 MCV     75 fL     80-100 fL    
 Iron     39 mcg/dL     50-170 mcg/dL    
 Ferritin     9 ng/mL     12-150 ng/mL    
 Total Iron Binding Capacity     427 mcg/dL     250-370 mcg/dL    
 Vitamin B12     500 pg/mL     160-950 pg/mL    
 Folate     10.0 ng/mL     2-20 ng/mL    

Transcript

Watch video only

Anemia in pregnancy is characterized by a decrease in the hemoglobin in a pregnant patient. Now, a normal physiologic anemia of pregnancy occurs when both the red blood cell mass and plasma volume expand throughout gestation. However, the increase of red blood cells is disproportionately less than the increase in plasma volume, resulting in a dilutional anemia, or physiologic anemia of pregnancy.

Other causes of anemia during pregnancy typically include nutritional deficiencies resulting in impaired red blood cell production. In addition, inherited mutations of hemoglobin structure, known as hemoglobinopathies, or conditions resulting in increased destruction of red blood cells can also be a cause of anemia during pregnancy.

Given the potential for blood loss at delivery, which will worsen a preexisting anemia, it is important to identify and treat anemia during pregnancy to prevent adverse maternal and fetal outcomes. Consequently, universal screening of all pregnant patients for anemia should be done during the first and second trimesters.

Your first step is to perform a universal screening of your pregnant patient for anemia at their first prenatal visit.

Keep in mind that some patients may not have received their prenatal care, so they may present with a chief concern suggesting anemia in pregnancy. Start by obtaining a focused history and physical exam. And since anemia is diagnosed based on hemoglobin values, a CBC is essential. Additionally, as part of universal screening, all patients should be screened for hemoglobinopathies using hemoglobin electrophoresis at the start of their pregnancy, unless they have had prior testing. A positive family history of hemoglobinopathy increases their risk of having one too. This is important because any patient with a hemoglobinopathy is at risk for anemia due to the abnormal hemoglobin structure resulting in defective hemoglobin molecules.

Other important risk factors include malabsorptive conditions, restrictive diets, or even pica, which is a craving to consume non-food items like starch, dirt, or ice, and can lead to anemia from inadequate folate, vitamin B12, and iron.

You may notice symptoms like fatigue or restless legs. Now, when it comes to the physical exam, a mild increase in heart rate of 10 to 15 beats per minute is normal during pregnancy; but if the patient is anemic, it might reveal tachycardia. Sometimes, you may see pallor or atrophic glossitis, where the tongue appears smooth and glossy with a red or pink background. You may also notice ataxia, which is a lack of balance or coordination.

Next, assess which trimester your patient is in and take a look at their CBC. For patients in the first or third trimester, a hemoglobin less than 11 g/dL is diagnostic of anemia; whereas, for patients in the second trimester, a hemoglobin of less than 10.5 g/dL is diagnostic of anemia.

Here is a high yield fact! A hemoglobin level less than 6 g/dL is considered a severe anemia. This low level is associated with abnormal fetal oxygenation which can lead to fetal demise. If your patient's hemoglobin is less than 6 g/dL, assess the fetal status and proceed with maternal transfusion of packed red blood cells.

Let's get back to patients who are anemic but without such a drastically low hemoglobin. For these patients you will use the mean corpuscular volume, or MCV, to guide your work up. Determining the exact cause will then tailor your management. When the MCV is below 80 femtoliters, this is considered a microcytic anemia.

To find the cause of a microcytic anemia, you should obtain labs, such as iron studies, which include ferritin, serum iron level, transferrin saturation, and serum total iron binding capacity, known as TIBC. If ferritin, serum iron, and transferrin saturation are low, and TIBC is high, then your diagnosis is iron deficiency anemia, which is actually the most common cause of microcytic anemia in pregnancy.

Here is a clinical pearl! While an entire iron panel is ordered and interpreted, ferritin is the most sensitive test for iron deficiency. In patients with early iron deficiency, ferritin may be the only abnormal lab.

Okay, let's talk about treatment for iron deficiency anemia,

Start with oral iron supplementation. Advise the patient to take one iron tablet three days per week, such as Monday, Wednesday, and Friday, since evidence suggests daily supplementation can limit absorption. Also, taking the iron on an empty stomach and with vitamin C, can maximize absorption. However, keep in mind that some patients may develop gastrointestinal side effects like nausea and vomiting. If your patient can't tolerate iron on an empty stomach, they may take it with food or right after meals.

After about a month of oral iron supplementation, repeat the CBC, and assess the response. If the hemoglobin has risen by a point, this suggests an adequate response and they can continue with oral iron. However, if hemoglobin doesn't improve significantly, there is an inadequate response. If this is the case, switch the patient from oral to IV iron supplementation.

Here's another clinical pearl! For anemic patients who cannot tolerate oral iron, have a known malabsorptive condition, or are severely iron deficient with a ferritin below 12, it is reasonable to go directly to IV iron without a trial of oral replacement.

Finally, let's take another look at iron studies. If the patient with microcytic anemia has normal ferritin, or normal iron studies, you should consider an alternative diagnosis, such as hemoglobinopathies or thalassemia, respectively.

Sources

  1. "ACOG practice bulletin no. 233: Anemia in pregnancy" Obstet Gynecol (2021)